Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
Learn more about:
Related Access Program
Georgetown University – Cholestasis of Parenteral Nutrition
Baylor College of Medicine – Cholestasis
Geisinger Clinic – Cholestasis
Rush University Medical Center – Cholestasis
Catherine Cibulskis, MD – Cholestasis
Georgetown University – Cholestasis
Children’s Hospital of Philadelphia – Cholestasis
Related Clinical Trial
FGF19 in Obstructive Cholestasis: “Unveil the Signal”
Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease
A Trial of Taurine Supplementation in Parenteral Nutrition 1
Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Gabapentin to Treat Itch in Patients With Liver Disease
Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat
Compassionate Use of Omegaven
Omegaven® as Parenteral Nutrition
A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP)
Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers
Compassionate Use of Omegaven IV Fat Emulsion
SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children
Omegaven as Alternative Parenteral Fat Nutrition
Minimization of IntraLipid Versus Omegaven
Compassionate Use of Omegaven IV Fat Emulsion
Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis
A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
Fibrates in Pediatric Cholestasis
Cholestasis Prevention: Efficacy of IV Fish Oil
Preventing Cholestasis Using SMOFLipid®
Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region